HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sun-Young Han Selected Research

KRC-108

7/2022Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects.
2/2016Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells.
6/2015Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells.
4/2012Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sun-Young Han Research Topics

Disease

19Neoplasms (Cancer)
07/2022 - 05/2005
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022 - 04/2011
4Carcinogenesis
08/2017 - 04/2006
3Stomach Neoplasms (Stomach Cancer)
03/2019 - 12/2011
3Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 04/2012
3Lung Neoplasms (Lung Cancer)
10/2013 - 05/2005
2Colonic Neoplasms (Colon Cancer)
07/2022 - 12/2017
2Wounds and Injuries (Trauma)
01/2022 - 01/2022
2Leukemia
06/2020 - 06/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016 - 02/2016
1Infections
01/2022
1Ventilator-Associated Pneumonia
01/2022
1Thyroid Neoplasms (Thyroid Cancer)
01/2021
1Idiopathic Pulmonary Fibrosis
08/2017
1Rheumatoid Arthritis
08/2017
1Hematologic Neoplasms (Hematological Malignancy)
11/2016
1Glioblastoma (Glioblastoma Multiforme)
06/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2016
1Carcinoma (Carcinomatosis)
02/2016
1Epilepsy (Aura)
02/2013
1Cerebral Hemorrhage
02/2013
1Brain Injuries (Brain Injury)
02/2013
1Hemorrhagic Stroke
02/2013
1Ischemic Stroke
02/2013
1Parkinson Disease (Parkinson's Disease)
06/2008
1Hearing Loss (Hearing Impairment)
06/2008
1Inflammation (Inflammations)
06/2008
1Autoimmune Diseases (Autoimmune Disease)
01/2005
1Dwarfism
06/2002

Drug/Important Bio-Agent (IBA)

11Phosphotransferases (Kinase)IBA
07/2022 - 04/2006
6Proteins (Proteins, Gene)FDA Link
07/2022 - 05/2005
5fms-Like Tyrosine Kinase 3IBA
07/2022 - 04/2011
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2022 - 05/2005
4KRC-108IBA
07/2022 - 04/2012
3Cadherins (E-Cadherin)IBA
02/2016 - 05/2005
2Pharmaceutical PreparationsIBA
01/2021 - 02/2013
2tyrosine receptor (receptor, tyrosine)IBA
06/2020 - 01/2018
2indirubinIBA
03/2019 - 04/2017
2EnzymesIBA
12/2017 - 10/2013
2SirtuinsIBA
06/2016 - 10/2013
1Phospholipases (Phospholipase)IBA
07/2022
1larotrectinibIBA
06/2021
1entrectinibIBA
06/2021
1LDD2269IBA
12/2017
1AgarIBA
12/2017
1Monoclonal AntibodiesIBA
08/2017
1Aurora Kinase AIBA
04/2017
1Tyrosine Kinase InhibitorsIBA
11/2016
1tenovin-1IBA
06/2016
1GalactosidasesIBA
06/2016
1ErbB Receptors (EGF Receptor)IBA
02/2016
1Antineoplastic Agents (Antineoplastics)IBA
02/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2016
1CateninsIBA
02/2016
1Histone DemethylasesIBA
02/2015
1Sirtuin 1IBA
10/2013
1Sirtuin 2IBA
10/2013
1toxoflavinIBA
10/2013
1Valproic Acid (Depakote)FDA LinkGeneric
02/2013
1Neuroprotective AgentsIBA
02/2013
1Heme Oxygenase-1IBA
02/2013
1Hemoglobins (Hemoglobin)IBA
02/2013
1D-JNKI-1IBA
06/2008
1Peptides (Polypeptides)IBA
06/2008
13,9-bis((ethylthio)methyl)-K-252aIBA
06/2008
1CC 401IBA
06/2008
1Interleukin-18 (Interleukin 18)IBA
01/2005
1Interleukin-12 (IL 12)IBA
01/2005
1MitogensIBA
01/2005
1brassinolideIBA
06/2002
1GibberellinsIBA
06/2002
1AzolesIBA
06/2002
1BrassinosteroidsIBA
06/2002

Therapy/Procedure

5Therapeutics
03/2022 - 04/2006
1Drug Therapy (Chemotherapy)
03/2022
1Mechanical Ventilators (Ventilator)
01/2022
1Oral Hygiene (Dental Hygiene)
01/2022
1Oral Administration
01/2021
1Intravenous Administration
01/2018